{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:16:06Z","timestamp":1767651366938},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":3238,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:p>Two years after completion of a controlled outcome study of treatments for panic disorder with agoraphobia, patients were revisited and interviewed about their complaints. In the initial study, four treatments had been compared: (i) fluvoxamine combined with exposure; (ii) placebo medication plus exposure; (iii) psychological panic management plus exposure: and (iv) exposure alone. Comparison of the results at post\u2010test had revealed superior efficacy of fluvoxamine combined with exposure over the other three treatments in reducing agoraphobic avoidance. The current naturalistic follow\u2010up study investigated the long\u2010term efficacy of the treatments with regard to abatement of complaints and reduced demand for further treatment. In addition, we examined whether patients were able to taper off the study medication without a recurrence of complaints. In total, 71 of the 76 patients of the original trial (93%) were interviewed. Comparison of the mean level of psychopathology at follow\u2010up revealed no difference between the original treatment groups. The effect in the fluvoxamine plus exposure group was maintained, but was no longer superior, due to further improvements in the other treatment groups. Most patients received additional treatment during the follow\u2010up period, usually because the 12 treatment sessions in the controlled study had yielded insufficient improvement. There was a trend for patients who received the fluvoxamine plus exposure treatment to require less aftercare than those who received the other treatments. Finally, almost 50% of the patients who had received medication in the original trial were able to taper off the use of fluvoxamine without a recurrence of complaints.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1999.tb05385.x","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T18:04:18Z","timestamp":1194977058000},"page":"59-67","source":"Crossref","is-referenced-by-count":29,"title":["Long\u2010term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2\u2010year naturalistic follow\u2010up"],"prefix":"10.1111","volume":"99","author":[{"given":"E.","family":"de Beurs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. L. M.","family":"van Balkom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Van","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.61.2.317"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199708000-00006"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/S0007125000035583","article-title":"Comment on the second phase of the cross\u2010national collaborative panic study","volume":"160","author":"Marks IM","year":"1992","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.4.465"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800160093011"},{"key":"e_1_2_1_7_2","volume-title":"Anxiety and its disorders: the nature and treatment of anxiety and panic","author":"Barlow DH","year":"1988"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.153.5.650"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.162.6.776"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-7358(82)90017-4"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7916(85)90026-6"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(89)90080-3"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0005-7894(05)80367-3","article-title":"Behavioral treatment of panic disorder: a two\u2010year follow\u2010up","volume":"22","author":"Craske MG","year":"1991","journal-title":"Behav Ther"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7894(05)80282-5"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.63.5.754"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.5.683"},{"key":"e_1_2_1_17_2","first-page":"1","volume-title":"Long\u2010term treatment of anxiety disorders","author":"Noyes R","year":"1996"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199602000-00015"},{"key":"e_1_2_1_19_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"1987"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(79)90041-X"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00048679509075898"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(85)90140-8"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.52.6.1090"},{"key":"e_1_2_1_24_2","volume-title":"SCL\u201090. Administration, scoring and procedures manual\u2010I for the R(evised) version and other instruments of the psychopathology rating scales series","author":"Derogatis LR","year":"1977"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_2_1_26_2","first-page":"65","article-title":"Depressiegevoelens bij psychiatrische patienten en hun partners: betrouwbaarheid en validiteit van de VROPSOM\u2010lijsten (Depressive moods of psychiatric out\u2010patients and their spouses: reliability and validity of the VROPSOM lists)","volume":"15","author":"Van Rooijen L","year":"1987","journal-title":"Gedrag & Gezondheid"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.47.2.319"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.59.1.12"},{"issue":"7","key":"e_1_2_1_29_2","first-page":"37","article-title":"Clinical management of anti\u2010depressant discontinuation","volume":"58","author":"Rosenbaum JF","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110035005"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199807000-00005"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.352"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.5.418"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199304000-00014"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130067010"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-6185(93)90009-A"},{"key":"e_1_2_1_37_2","first-page":"163","article-title":"Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow\u2010up study","volume":"50","author":"Noyes R","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_38_2","first-page":"146","article-title":"The abrupt discontinuation of fluvoxamine in patients with panic disorder","volume":"54","author":"Black DW","year":"1993","journal-title":"J Clin Psychiatry"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1999.tb05385.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1999.tb05385.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T14:40:42Z","timestamp":1698504042000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1999.tb05385.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1111\/j.1600-0447.1999.tb05385.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1999.tb05385.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}